The DOI matches its Crossref record.
The epidemiology of Wegener's granulomatosis. Estimates of the five‐year period prevalence, annual mortality, and geographic disease distribution from population‐based data sources
Abstract
Objective. To estimate the prevalence, annual mortality, and geographic distribution of Wegener's granulomatosis. Methods. Analysis of national vital statistics data and hospitalization data from a national survey and from all New York State inpatient facilities. Results. Between 1979 and 1988, 1,784 death certificates in the United States listed Wegener's granulomatosis as a cause of death. Nationally, an estimated 10,771 hospitalizations included Wegener's granulomatosis among the discharge diagnoses. In New York State, there were 978 hospitalizations among 571 individuals with Wegener's granulomatosis. Conclusion. The prevalence of Wegener's granulomatosis in the United States is approximately 3.0 per 100,000 persons. Clear differences in the geographic distribution of Wegener's granulomatosis are apparent when analyses consider rates of disease in individual counties. Contrary to previous reports, associations between disease exacerbations and season were not apparent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kitching, A. R., Anders, H.-J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 928
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Korkmaz, B., Horwitz, M. S., Jenne, D. E., & Gauthier, F. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002733 · Cited by 870
Mahr, A., Guillevin, L., Poissonnet, M., & Aymé, S. (2004) · Arthritis Care & Research · doi:10.1002/art.20077 · Cited by 550
Occupational exposure to crystalline silica and autoimmune disease.
Parks, C. G., Conrad, K., & Cooper, G. S. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s5793 · Cited by 324
Reinhold‐Keller, E., Herlyn, K., Wagner‐Bastmeyer, R., & Gross, W. L. (2005) · Arthritis Care & Research · doi:10.1002/art.20928 · Cited by 303
Metadata
- Authors
- Cotch, M. F., Hoffman, G. S., Yerg, D. E., Kaufman, G. I., Targonski, P., & Kaslow, R. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-01
- Volume
- 39
- Issue
- 1
- Pages
- 87-92
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2101093436
- Cited by
- 327
- References
- 0
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epidemiology of Wegener's granulomatosis. Estimates of the five‐year period prevalence, annual mortality, and geographic disease distribution from population‐based data sources. https://app.cochat.ai/papers/10.1002/art.1780390112
- The paper
- Cotch, M. F., Hoffman, G. S., Yerg, D. E., Kaufman, G. I., Targonski, P., & Kaslow, R. A. (1996). The epidemiology of Wegener's granulomatosis. Estimates of the five‐year period prevalence, annual mortality, and geographic disease distribution from population‐based data sources. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780390112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.